BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 12552444)

  • 21. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.
    Lillo FB; Ferrari D; Veglia F; Origoni M; Grasso MA; Lodini S; Mastrorilli E; Taccagni G; Lazzarin A; Uberti-Foppa C
    J Infect Dis; 2001 Sep; 184(5):547-51. PubMed ID: 11494160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of high risk human papillomavirus-capsid antibodies in human immunodeficiency virus-seropositive men: a serological study.
    Höpfl R; Petter A; Thaler P; Sarcletti M; Widschwendter A; Zangerle R
    BMC Infect Dis; 2003 Apr; 3():6. PubMed ID: 12723991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States.
    Thompson DL; Douglas JM; Foster M; Hagensee ME; Diguiseppi C; Barón AE; Cameron JE; Spencer TC; Zenilman J; Malotte CK; Bolan G; Kamb ML; Peterman TA;
    J Infect Dis; 2004 Nov; 190(9):1563-74. PubMed ID: 15478060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anal human papillomavirus DNA screening by Hybrid Capture II in human immunodeficiency virus-positive patients with or without anal intercourse.
    Drobacheff C; Dupont P; Mougin C; Bourezane Y; Challier B; Fantoli M; Bettinger D; Laurent R
    Eur J Dermatol; 2003; 13(4):367-71. PubMed ID: 12948917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women.
    Ahdieh L; Klein RS; Burk R; Cu-Uvin S; Schuman P; Duerr A; Safaeian M; Astemborski J; Daniel R; Shah K
    J Infect Dis; 2001 Sep; 184(6):682-90. PubMed ID: 11517428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles.
    Ho GY; Studentsov Y; Hall CB; Bierman R; Beardsley L; Lempa M; Burk RD
    J Infect Dis; 2002 Sep; 186(6):737-42. PubMed ID: 12198606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Markers of human papillomavirus infection and their correlation with cervical dysplasia in human immunodeficiency virus-positive women.
    Riva E; Serraino D; Pierangeli A; Bambacioni F; Zaniratti S; Minosse C; Selleri M; Bucci M; Scagnolari C; Degener AM; Capobianchi MR; Antonelli G; Dianzani F;
    Clin Microbiol Infect; 2007 Jan; 13(1):94-7. PubMed ID: 17184295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection.
    Mbulawa ZZ; Coetzee D; Marais DJ; Kamupira M; Zwane E; Allan B; Constant D; Moodley JR; Hoffman M; Williamson AL
    J Infect Dis; 2009 May; 199(10):1514-24. PubMed ID: 19392625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of human papillomavirus infection and disease with magnitude of human immunodeficiency virus type 1 (HIV-1) RNA plasma level among women with HIV-1 infection.
    Luque AE; Demeter LM; Reichman RC
    J Infect Dis; 1999 Jun; 179(6):1405-9. PubMed ID: 10228061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women.
    Denny L; Boa R; Williamson AL; Allan B; Hardie D; Stan R; Myer L
    Obstet Gynecol; 2008 Jun; 111(6):1380-7. PubMed ID: 18515522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women.
    Watts DH; Fazzari M; Minkoff H; Hillier SL; Sha B; Glesby M; Levine AM; Burk R; Palefsky JM; Moxley M; Ahdieh-Grant L; Strickler HD
    J Infect Dis; 2005 Apr; 191(7):1129-39. PubMed ID: 15747249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases.
    Heard I; Palefsky JM; Kazatchkine MD
    Antivir Ther; 2004 Feb; 9(1):13-22. PubMed ID: 15040532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection.
    Lillo FB; Lodini S; Ferrari D; Stayton C; Taccagni G; Galli L; Lazzarin A; Uberti-Foppa C
    Clin Infect Dis; 2005 Feb; 40(3):451-7. PubMed ID: 15668870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus infection in men who have sex with men participating in a Dutch gay-cohort study.
    van der Snoek EM; Niesters HG; Mulder PG; van Doornum GJ; Osterhaus AD; van der Meijden WI
    Sex Transm Dis; 2003 Aug; 30(8):639-44. PubMed ID: 12897686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus (HPV) detection among human immunodeficiency virus-infected pregnant Thai women: implications for future HPV immunization.
    Bollen LJ; Chuachoowong R; Kilmarx PH; Mock PA; Culnane M; Skunodom N; Chaowanachan T; Jetswang B; Neeyapun K; Asavapiriyanont S; Roongpisuthipong A; Wright TC; Tappero JW
    Sex Transm Dis; 2006 Apr; 33(4):259-64. PubMed ID: 16452834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected women from South Africa, Brazil and Botswana.
    Firnhaber C; Evans D; Friedman-Khalili R; Willliams S; Michelow P; Matlhagela K; Wester C; Grinsztejn B; Lockman S
    J Clin Virol; 2011 Nov; 52(3):265-8. PubMed ID: 21908233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary care of HPV management in HIV-infected women.
    Dole PJ
    Nurse Pract Forum; 2001 Dec; 12(4):214-22. PubMed ID: 11889689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervicovaginal shedding of TT virus in HIV-infected women.
    Calcaterra S; Zaniratti MS; Serraino D; Peroni M; Abbate I; Cappiello G; Piselli P; Pavia C; Rezza G; Ippolito G; Capobianchi MR
    J Hum Virol; 2001; 4(6):343-5. PubMed ID: 12082401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associated risk factors of human papillomavirus cervical infection among human immunodificiency virus-seropositive women at Siriraj Hospital.
    Sirimai K; Chalermchockcharoenkit A; Roongpisuthipong A; Pongprasobchai S
    J Med Assoc Thai; 2004 Mar; 87(3):270-6. PubMed ID: 15117043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Human papillomavirus and human immunodeficiency virus infections as risk factors for cervix cancer in women prisoners].
    de Sanjosé S; Valls I; Paz Cañadas M; Lloveras B; Quintana MJ; Shah KV; Bosch FX
    Med Clin (Barc); 2000 Jun; 115(3):81-4. PubMed ID: 10965480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.